111 related articles for article (PubMed ID: 17674964)
1. Future strategies for targeted therapies and tailored patient management in pancreatic cancer.
Ko AH
Semin Oncol; 2007 Aug; 34(4):354-64. PubMed ID: 17674964
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future.
Cohenuram M; Saif MW
JOP; 2007 Jan; 8(1):4-15. PubMed ID: 17228128
[TBL] [Abstract][Full Text] [Related]
3. Targeted agents in the treatment of pancreatic cancer: history and lessons learned.
Bendell J; Goldberg RM
Curr Opin Oncol; 2007 Jul; 19(4):390-5. PubMed ID: 17545806
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies: a nursing perspective.
Kay P
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
[TBL] [Abstract][Full Text] [Related]
5. Review: side effects of approved molecular targeted therapies in solid cancers.
Widakowich C; de Castro G; de Azambuja E; Dinh P; Awada A
Oncologist; 2007 Dec; 12(12):1443-55. PubMed ID: 18165622
[TBL] [Abstract][Full Text] [Related]
6. Advanced or metastatic pancreatic cancer: molecular targeted therapies.
Bayraktar S; Rocha-Lima CM
Mt Sinai J Med; 2010; 77(6):606-19. PubMed ID: 21105124
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
Strimpakos A; Saif MW; Syrigos KN
Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: from molecular signature to target therapy.
Longo R; Cacciamani F; Naso G; Gasparini G
Crit Rev Oncol Hematol; 2008 Dec; 68(3):197-211. PubMed ID: 18436450
[TBL] [Abstract][Full Text] [Related]
9. Targeted agents and esophageal cancer--the next step?
Aklilu M; Ilson DH
Semin Radiat Oncol; 2007 Jan; 17(1):62-9. PubMed ID: 17185199
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapy of ovarian cancer.
Nicodemus CF; Berek JS
Expert Rev Anticancer Ther; 2005 Feb; 5(1):87-96. PubMed ID: 15757441
[TBL] [Abstract][Full Text] [Related]
12. Biology of interactions: antiepidermal growth factor receptor agents.
Harari PM; Allen GW; Bonner JA
J Clin Oncol; 2007 Sep; 25(26):4057-65. PubMed ID: 17827454
[TBL] [Abstract][Full Text] [Related]
13. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
14. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
15. Novel therapies for pancreatic cancer.
Wolff RA
Cancer J; 2001; 7(4):349-58. PubMed ID: 11561610
[TBL] [Abstract][Full Text] [Related]
16. The promise and perils of 'targeted therapy' of advanced ovarian cancer.
Markman M
Oncology; 2008; 74(1-2):1-6. PubMed ID: 18536523
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for advanced pancreatic cancer.
Middleton G; Ghaneh P; Costello E; Greenhalf W; Neoptolemos JP
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):673-96. PubMed ID: 19072345
[TBL] [Abstract][Full Text] [Related]
18. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
Albo D; Farrow B; Berger DH
Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Modjtahedi H; Essapen S
Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]